Fig. 5
The batoclimab, efgartigimod, and rituximab as the most commonly reported interventions in the studies included
Fig. 5 | Systematic Reviews
The batoclimab, efgartigimod, and rituximab as the most commonly reported interventions in the studies included
Systematic Reviews